ROTOP Pharma

ROTOP Pharmaka is a specialized pharmaceutical company focused on the development, production, and distribution of radiopharmaceuticals for diagnostic imaging and targeted therapy. Based in Dresden, Germany, the company is a leading supplier of Technetium-99m cold kits used in nuclear medicine for indications in oncology, nephrology, and cardiology. In addition to its proprietary product portfolio, ROTOP operates as a full-service CDMO, providing GMP-compliant manufacturing, R&D, and global logistics for radioactive medicinal products. The company plays a vital role in the radiopharmaceutical supply chain, particularly in the production of therapeutic isotopes like Lutetium-177. In 2021, ROTOP was acquired by Curium, a global leader in nuclear medicine, to expand its manufacturing footprint and product offerings.